Randy Hofmann

Randy Hofmann, PhD, is a seasoned professional in the biotechnology and pharmaceutical sectors with extensive experience in research, leadership, and project management. Currently serving as the Biotechnology Branch Supervisor at Excet, Incorporated since March 2011, Randy oversees a team of 9-10 staff members while also fulfilling responsibilities as a Principal Scientist and Group Leader for the Defense Biological Product Assurance Office. Previous roles include leading significant projects at Garnet BioTherapeutics, GlaxoSmithKline, and conducting post-doctoral research at Cold Spring Harbor Laboratory and the University of Zurich. Randy holds a Ph.D. in Cancer Biology from the University of Maryland School of Medicine and a B.S. in Biology from Loyola University Maryland.